TETology: Epigenetic Mastermind in Action.

Area of Science:

• Epigenetics and Epitranscriptomics
• Molecular Biology
• Genetics

Background:

• Cytosine methylation, mediated by DNA methyltransferases (DNMTs), is a key epigenetic modification.
• Ten-eleven translocation (TET) proteins are Fe(II) and alpha-ketoglutarate-dependent dioxygenases that edit DNA methylation.
• TET proteins catalyze the conversion of 5-methylcytosine to 5-hydroxymethylcytosine and further oxidized derivatives.

Purpose of the Study:

• To review the structure, catalysis, and physiological functions of TET proteins, with a focus on TET2.
• To elaborate on the pathological alterations associated with TET2 in various diseases.
• To discuss methods for studying TET2, emphasizing its roles in epigenomics and epitranscriptomics.

Main Methods:

• Literature review of studies on TET proteins, focusing on TET2.
• Analysis of TET2 structure, function, and mutations.
• Exploration of TET2's involvement in epigenetics and epitranscriptomics.

Main Results:

• TET2, unlike TET1 and TET3, lacks a CXXC domain and requires protein interactions for DNA binding.
• TET2 functions as a methylation editor for both DNA and RNA.
• TET2 mutations are implicated in hematological malignancies (e.g., AML, MDS) and non-hematological cancers (e.g., hepatocellular carcinoma, gastric cancer).
• Loss of TET2 is also associated with non-malignant conditions like atherosclerotic vascular lesions and endometriosis.

Conclusions:

• TET2 plays a pleiotropic role in both hematopoietic and non-hematopoietic systems.
• TET2 is a critical regulator in epigenetics and epitranscriptomics, with significant implications in disease pathogenesis.
• Further research into TET2's functions and associated pathologies is warranted.